Herceptin : Le Médicament qui a Révolutionné le Cancer du Sein 
#Herceptin #Trastuzumab #CancerDuSein #HER2 #Cancer #Oncologie #OctobreRose #RYvolution

Cancer du Sein HER2+ : Plus Agressif, Mais Mieux Ciblé !
#CancerDuSein #HER2 #Cancer #Oncologie #OctobreRose #RYvolution

FDA OKs Pfizer’s TUKYSA for Front‑line Maintenance in HER2‑Positive Metastatic Breast Cancer

#her2 #breastcancer #pfizer #fda

Patients with estrogen receptor–positive, #HER2 -negative advanced #BreastCancer experienced significantly longer progression-free survival when treated with an oral #CombinationTherapy that included #giredestrant, a next-generation selective #EstrogenReceptor degrader and complete antagonist.

Methylcobalamin reduces severe hand-foot syndrome in HER2- breast cancer patients.
🧪 14.5% vs 29.1% incidence
📉 -14.5% risk difference
No specific AEs. #HER2 #Methylcobalamin

https://tnyp.me/ztty7zj2/s

Biocon's Pertuzumab: A Milestone Biosimilar Approved for HER2-Positive Breast Cancer #India #Bengaluru #Biocon #HER2-positive #Pertuzumab

DESTINY-Lung04 : #Enhertu bat chimio+pembro en 1L #CBNPC HER2+
• SSP : 14,3 vs 8,3m
• TRG : 70% vs 44,5%
• SG : 29,3 vs 33,1m

www.ipharmacenter.com/post/iaslc-2...

#WCLC26 #WCLC2026 #OncoAlert #OncoTwitter #news #media #CancerDuPoumon #HER2

DESTINY-Lung04: #Enhertu supera quimio+pembro en 1L #CPNM HER2+
• SLP: 14,3 vs 8,3m
• TRO: 70% vs 44,5%
• SG: 29,3 vs 33,1m

www.ipharmacenter.com/post/iaslc-2...

#WCLC26 #WCLC2026 #OncoAlert #OncoTwitter #news #media #CáncerDePulmón #HER2

🤔 Can one #nanoparticle deliver chemo + #targeted therapy + #antibody? This study co-loads docetaxel & neratinib + trastuzumab. Superior #tumor regression in #HER2+ models—first to combine all three!

👉 www.mdpi.com/1999-4923/17...
#BreastCancer #Nanoparticles #HER2 #DrugDelivery

Thank you to #waifu.rachel and #Amethyst for reposting #mishamai_hime video on #Instagram. I'm sharing the #gofundme link in order to help gather support for her #breastcancer treatment. #krakenroyalty #snkyoctogaming #otakugamer #weeb #phuqcancer #her2 #youmatter gofund.me/cddb8c9be

Groundbreaking Phase 3 Trial Reveals Benefits of Trastuzumab Deruxtecan in HER2-Mutant Lung Cancer #South_Korea #Seoul #Trastuzumab_Deruxtecan #HER2-Mutant_NSCLC #DESTINY-Lung04

Promising Phase III Results of Trastuzumab Botidotin Offers Hope for HER2-Positive Breast Cancer Patients #China #Chengdu #Kelun-Biotech #HER2 #Trastuzumab_Botidotin

Tratamiento neoadyuvante con taxano, trastuzumab y pertuzumab alcanza la respuesta patológica completa en casi dos tercios de pacientes con cáncer de mama HER2+/ER- y un tercio con HER2+/ER+ #response #breastcancer #HER2+ ascopubs.org/doi/abs/10.1...